圣阳股份(002580) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 reached ¥586,922,515.63, representing a 39.99% increase compared to ¥419,265,277.04 in the same period last year[4] - Net profit attributable to shareholders was ¥45,572,538.74, marking a significant increase of 111.82% from ¥21,514,316.31 year-on-year[4] - The basic earnings per share doubled to ¥0.10 from ¥0.05, reflecting a 100% increase[4] - Net profit for Q1 2023 was CNY 45,297,562.79, representing a 109.9% increase compared to CNY 21,571,754.81 in Q1 2022[20] - Earnings per share for Q1 2023 were CNY 0.10, doubling from CNY 0.05 in the same quarter last year[20] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,094,753,397.82, a 2.10% increase from ¥3,031,054,099.85 at the end of the previous year[4] - Total liabilities decreased to RMB 1,000,000,000 from RMB 1,200,000,000, indicating a reduction of 16.7%[15] - Total liabilities as of Q1 2023 were CNY 1,035,935,928.33, slightly up from CNY 1,031,539,021.55 at the end of the previous year[19] - Total equity increased to CNY 2,058,817,469.49 from CNY 1,999,515,078.30 in the previous year[19] Cash Flow - Cash flow from operating activities improved to -¥128,783,770.29, a 10.91% reduction in negative cash flow compared to -¥144,552,674.78 in the previous year[4] - The company reported a significant increase in cash inflow from operating activities, totaling ¥57,497.61 million compared to ¥42,534.91 million in the previous year[10] - Cash flow from operating activities was CNY 544,015,776.18, an increase from CNY 416,020,731.69 in the previous year[22] - Total cash inflow from operating activities was 574,976,128.03 CNY, compared to 425,349,090.91 CNY in the same period last year, representing a 35.2% increase[23] - The company reported a total cash outflow from operating activities of 703,759,898.32 CNY, compared to 569,901,765.69 CNY last year, reflecting a 23.4% increase[23] Research and Development - Research and development expenses increased by 55.00% to ¥1,753.95 million, up from ¥1,131.59 million, indicating a focus on innovation[9] - Research and development expenses rose to CNY 17,539,481.83, a 55.0% increase from CNY 11,315,887.69 in Q1 2022[19] Investments and Financing - The company recorded a significant increase in investment income, rising by 84,342.86% to ¥59.11 million from ¥0.07 million in the previous year[9] - The company reported a significant increase in net investment income to CNY 591,082.84 from CNY 733.69 in the previous year[19] - The company’s long-term borrowings increased by 123.31% to ¥15,221.49 million, up from ¥6,816.37 million, indicating increased leverage[9] - The company received 14,000,000.00 CNY from investment absorption and 84,000,000.00 CNY from loans during the financing activities[23] Market Strategy and Outlook - The company is focusing on expanding its market presence and enhancing product development strategies[14] - Future outlook includes potential mergers and acquisitions to strengthen market position and drive growth[14]